A Dual Approach for Pterygium Removal
Optimizing pterygium removal with conjunctival autograft and amniotic membrane graft
By
Himani Goyal
September 7, 2026
Clinical Scorecard: A Dual Approach for Pterygium Removal
At a Glance
Category Detail
Condition Pterygium Key Mechanisms Fibrovascular conjunctival tissue encroaches onto the cornea, influenced by UV radiation and other factors. Target Population Older patients, men, and those with dry eye disease or chronic irritation. Care Setting Ophthalmology surgical practice
Key Highlights
Pterygium prevalence is around 10%, higher in equatorial populations. Recurrence rates after pterygium excision can be as high as 18%. Combined conjunctival autograft and amniotic membrane graft shows recurrence rates of around 1%. Inflammation management is crucial pre- and postoperatively. Patient education on sun protection and postoperative care is essential. Guideline-Based Recommendations
Diagnosis
Diagnosis based on clinical examination of ocular surface changes. Management
Surgical excision is definitive; consider combined CAG and AMG for better outcomes. Monitoring & Follow-up
Monitor for recurrence and manage inflammation postoperatively. Risks
Higher recurrence in males and patients under 40; consider alternative strategies in glaucoma patients. Patient & Prescribing Data
Patients with symptomatic pterygium requiring surgical intervention.
Use topical steroids preoperatively and a regimen of prednisolone acetate and antibiotic drops postoperatively.
Clinical Best Practices
Utilize cryopreserved amniotic membranes for better healing outcomes. Employ meticulous surgical techniques to minimize recurrence. Educate patients on sun protection and postoperative care. Related Resources & Content
